Trilogy Capital’s iShares Morningstar Mid-Cap Growth ETF IMCG Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCG
MTC
Trilogy Capital's IMCG Position: Q3 2026 in Review
Trilogy Capital increased its iShares Morningstar Mid-Cap Growth ETF (IMCG) stake by 0.06% in Q3 2026, buying an estimated $193 and bringing the position to 3,616 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #317.
Trilogy Capital first reported a position in IMCG in Q2 2025 and has held it in 6 quarters since. The position peaked at $635K in Q3 2025. 128 funds tracked by Wall St. Rank hold IMCG as of Q3 2026.
- Trilogy Capital held 3,616 shares of iShares Morningstar Mid-Cap Growth ETF worth $340K as of Q3 2026.
- Trilogy Capital bought 2 iShares Morningstar Mid-Cap Growth ETF shares in Q3 2026, an estimated $193.
- iShares Morningstar Mid-Cap Growth ETF made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #317 holding.
- Trilogy Capital first reported a position in iShares Morningstar Mid-Cap Growth ETF in Q2 2025 and has held it in 6 quarters since.
- Trilogy Capital's iShares Morningstar Mid-Cap Growth ETF position peaked at $635K in Q3 2025.
- 128 funds tracked by Wall St. Rank held iShares Morningstar Mid-Cap Growth ETF as of Q3 2026.
Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.